We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.68B
AUM Growth
-$145M
Cap. Flow
-$113M
Cap. Flow %
-2.41%
Top 10 Hldgs %
14.09%
Holding
1,671
New
224
Increased
657
Reduced
447
Closed
328

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$29M
2
NU icon
Nu Holdings
NU
+$25.8M
3
PG icon
Procter & Gamble
PG
+$23.5M
4
NKE icon
Nike
NKE
+$23.1M
5
GRAB icon
Grab
GRAB
+$22.3M

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$44.7M
2
NTES icon
NetEase
NTES
+$40.5M
3
AMD icon
Advanced Micro Devices
AMD
+$37.8M
4
MELI icon
Mercado Libre
MELI
+$33.9M
5
PDD icon
Pinduoduo
PDD
+$33.8M

Sector Composition

Rank Sector Weight
1 Technology 30.82%
2 Consumer Discretionary 19.78%
3 Communication Services 10.14%
4 Financials 6.66%
5 Industrials 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JKHY icon
1451
Jack Henry & Associates
JKHY
$11.1B
– –
-273
Closed -$44K
JQUA icon
1452
JPMorgan US Quality Factor ETF
JQUA
$8.48B
– –
-808
Closed -$33K
KALA icon
1453
KALA BIO
KALA
$14.5M
– –
-1
Closed -$3K
KALV
1454
DELISTED
KalVista Pharmaceuticals
KALV
– –
-560
Closed -$9K
KMDA icon
1455
Kamada
KMDA
$419M
– –
-1,025
Closed -$5K
KNSA icon
1456
Kiniksa Pharmaceuticals
KNSA
$5.93B
– –
-745
Closed -$8K
KOD icon
1457
Kodiak Sciences
KOD
$2.84B
– –
-1,180
Closed -$113K
KPTI icon
1458
Karyopharm Therapeutics
KPTI
$48M
– –
-115
Closed -$10K
KROS icon
1459
Keros Therapeutics
KROS
$221M
– –
-535
Closed -$21K
KRRO icon
1460
Korro Bio
KRRO
$195M
– –
-16
Closed -$5K
KRYS icon
1461
Krystal Biotech
KRYS
$9.66B
– –
-510
Closed -$26K
KURA icon
1462
Kura Oncology
KURA
$850M
– –
-1,515
Closed -$28K
KZR
1463
DELISTED
Kezar Life Sciences
KZR
– –
-110
Closed -$9K
LEGN icon
1464
Legend Biotech
LEGN
$4.01B
– –
-720
Closed -$36K
LOVE
1465
LoveSac
LOVE
$261M
– –
-39,053
Closed -$2.58M
LRMR icon
1466
Larimar Therapeutics
LRMR
$432M
– –
-405
Closed -$4K
LSPD icon
1467
Lightspeed Commerce
LSPD
$1.35B
– –
-82,183
Closed -$7.92M
MATX icon
1468
Matsons
MATX
$6.18B
– –
-1,107
Closed -$89K
MCRB icon
1469
Seres Therapeutics
MCRB
$48.4M
– –
-105
Closed -$14K
MDGL icon
1470
Madrigal Pharmaceuticals
MDGL
$11.8B
– –
-380
Closed -$30K
MDT icon
1471
Medtronic
MDT
$112B
– –
-162,709
Closed -$20.4M
MEDP icon
1472
Medpace
MEDP
$16.5B
– –
-820
Closed -$155K
MGNX icon
1473
MacroGenics
MGNX
$257M
– –
-1,400
Closed -$29K
MGTX icon
1474
MeiraGTx Holdings
MGTX
$1.21B
– –
-1,010
Closed -$13K
MNDY icon
1475
monday.com
MNDY
$3.94B
– –
-15,618
Closed -$5.09M
57 58
59
60 61

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Penserra Capital Management held 1,671 positions worth $4.68B, down 3% from $4.82B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Penserra Capital Management's Q4 2021 filing shows 224 new, 657 increased, 447 reduced and 328 closed positions. Its largest new stake was Marathon Petroleum: 451,379 shares worth $28.9M. The largest sale was JD.com, an estimated $44.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Penserra Capital Management's largest Q4 2021 buy was Marathon Petroleum: 451,379 shares worth $28.9M.
  • Penserra Capital Management added most to Procter & Gamble in Q4 2021, an estimated $23.5M increase.
  • Penserra Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $44.7M.
  • Penserra Capital Management fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $32.7M.
  • Penserra Capital Management's ten largest holdings make up 14% of its $4.68B portfolio in Q4 2021.
  • Penserra Capital Management opened 224 new positions and closed 328 in Q4 2021.
  • Penserra Capital Management's portfolio value fell 3% quarter-over-quarter to $4.68B.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.